FDA Clearance Tracker · P040013-S016
GEM 21S GROWTH FACTOR ENHANCED MATRIX
Last checked: Nov 20, 2026Latest source record: May 27, 2011 (this decision)Source: openFDAMethods & limitations
Decided
May 27, 2011
Approved
Time to decision
167 days
Received Dec 11, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P040013-S016
- Device name
- GEM 21S GROWTH FACTOR ENHANCED MATRIX
- Applicant
- Lynch Biologics, LLC
- Applicant location
- Franklin, TN
- Received
- Dec 11, 2010
- Decided
- May 27, 2011
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P040013
Device type
- Device class
- Class III
- Regulation
- 21 CFR 872.3930
- Specialty
- Dentistry & Oral Surgery
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A CHANGE IN THE RH-PDGF-BB SYRINGE CAP MATERIAL, MADE BY BECTON DICKINSON, THE CAP SUPPLIER, FROM WEST 1883 TO HELOVET FM27, BASED ON A CHANGE IN BECTON DICKINSON RUBBER RAW MATERIALS SUPPLIERS.
Source documents
Other decisions for Lynch Biologics, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.